A comprehensive study evaluating germline <scp><i>FANCG</i></scp> variants in predisposition to breast and ovarian cancer

Our study suggests that heterozygous germline FANCG variants are unlikely to contribute to the development of BC or OC.

Authors

Institutions

Publication Details

Journal
Cancer Medicine
Published
2024-08-01
DOI
https://doi.org/10.1002/cam4.70103
Citations
4
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
1.13

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer

Zdeňka Vlčková, Václava Curtisová, Tomáš Zima, Zdeněk Kleibl et al.
4 citations
Cancer Medicine
PARP inhibition in cancer therapy
1.13
article

A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer

Zdeňka Vlčková, Václava Curtisová, Tomáš Zima, Zdeněk Kleibl, Marta Kalousová, Jana Soukupová, Markéta Janatová, Viktor Stránecký, Milena Hovhannisyan, Petr Nehasil, Klára Horáčková, Kateřina Matějková, Monika Koudová, Barbora Šťastná, Štěpán Chvojka, Ondřej Scheinost, Vera Krutilkova, Matous Palek, Petra Kleiblová, Marcela Kosařová, Lenka Foretová, Petra Zemánková, J. Hojný, Sandra Jelínková, Libor Macůrek, Jan Král, Ondřej Havránek, Michaela Krausová, Marta Černá, Leona Cerna, Lucie Hrušková, Marianna Borecká, Ivan Šubrt, Lenka Stolařová, Mária Janíková, Spiros Tavandzis, Michal Vočka, Pavel Just, Markéta Šafaříková, Eva Macháčková, Drahomíra Springer, Petra Duskova, Renáta Michalovská, Taťána Doležalová, Pavel Pesek, Eva Tureckova, Jan Novotný, Monika Černá, Kamila Vesela, Barbora Němcová, Madiha Kanwal
article en
4 citations

Abstract

Our study suggests that heterozygous germline FANCG variants are unlikely to contribute to the development of BC or OC.

Cancer MedicineVol. 13(16)
Charles University (CZ), University Hospital Olomouc (CZ), Masaryk Memorial Cancer Institute (CZ), Nemocnice České Budějovice (CZ), Institute of Clinical and Experimental Medicine (CZ), Czech Academy of Sciences, Institute of Molecular Genetics (CZ), General University Hospital in Prague (CZ), Palacký University Olomouc (CZ)
Univerzita Karlova v Praze, Grantová Agentura, Univerzita Karlova, Ministerstvo Školství, Mládeže a Tělovýchovy, Ministerstvo Zdravotnictví Ceské Republiky
Good health and well-being
Openalex Percentile: Top 19%
PARP inhibition in cancer therapy
1.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.